A Project to Test the Efficacy and Safety of An Innovative Treatment for Opiate Use Disorders.
MindLight, LLC
MindLight, LLC
Sunnybrook Health Sciences Centre
Maastricht University
Fondazione Italiana Linfomi - ETS
Chinese University of Hong Kong
Heidelberg University
Shanghai Ming Ju Biotechnology Co., Ltd.
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Massachusetts General Hospital
Noordwest Ziekenhuisgroep
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Huashan Hospital
NovalGen Ltd.
Universita di Verona
Bar-Ilan University, Israel
Assistance Publique Hopitaux De Marseille
Chinese PLA General Hospital
Deepsonbio
Groupe Maladies hémorragiques de Bretagne
Assistance Publique - Hôpitaux de Paris
St. Joseph's Hospital and Medical Center, Phoenix
Decathlon SE
Zhejiang University
University Hospital, Bonn
The First Affiliated Hospital of Soochow University
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Qilu Puget Sound Biotherapeutics (dba Sound Biologics)
University College, London
Sun Yat-sen University
Chinese University of Hong Kong
Hopital Foch
Hrain Biotechnology Co., Ltd.
University of Ulster
Gilead Sciences
Gilead Sciences
Centro Universitário de Anapolis
Meir Medical Center
National Institute of Health Research and Development, Ministry of Health Republic of Indonesia
Ludwig-Maximilians - University of Munich
Ruijin Hospital
Huazhong University of Science and Technology
Nanjing Sanhome Pharmaceutical, Co., Ltd.
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Oncotartis, Inc.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Shanghai YingLi Pharmaceutical Co. Ltd.
Shanghai YingLi Pharmaceutical Co. Ltd.
University of Uyo Teaching Hospital
Ruijin Hospital
China-Japan Friendship Hospital